Decreased microvascular claudin-5 levels in cerebral amyloid angiopathy associated with intracerebral haemorrhage.
Claudin‐5
blood–brain barrier
cerebral amyloid angiopathy
immunohistochemistry
intracerebral haemorrhage
Journal
Brain pathology (Zurich, Switzerland)
ISSN: 1750-3639
Titre abrégé: Brain Pathol
Pays: Switzerland
ID NLM: 9216781
Informations de publication
Date de publication:
19 May 2024
19 May 2024
Historique:
received:
30
01
2024
accepted:
30
04
2024
medline:
20
5
2024
pubmed:
20
5
2024
entrez:
19
5
2024
Statut:
aheadofprint
Résumé
Decreased microvascular levels of claudin-5 in the occipital and temporal lobe of patients with cerebral amyloid angiopathy are associated with intracerebral haemorrhage.
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13270Subventions
Organisme : Foundation for the National Institutes of Health
ID : 5R01NS104147-02
Organisme : The Galen and Hilary Weston Foundation
ID : NR170024
Organisme : Alzheimer Nederland
ID : WE.03-2022-17
Organisme : ZonMw
ID : 733050822
Pays : Netherlands
Organisme : Stichting Alkemade-Keuls, Maag-Lever-Darm-stichting
ID : WOO 2105
Organisme : Parkinson NL
ID : P2-21-18
Organisme : ZonMW-Dementia program
ID : 10510032120006
Organisme : ZonMW-Dementia program
ID : 10510032120003
Organisme : Dutch Heart Foundation
ID : 2019T060
Organisme : Dutch Heart Foundation
ID : CVON2015-01: CONTRAST
Organisme : Brain Foundation Netherlands
ID : HA2015.01.06
Organisme : Ministry of Economic Affairs
ID : LSHM17016
Informations de copyright
© 2024 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.
Références
Jäkel L, De Kort AM, Klijn CJM, Schreuder F, Verbeek MM. Prevalence of cerebral amyloid angiopathy: a systematic review and meta‐analysis. Alzheimers Dement. 2022;18(1):10–28.
Freeze WM, Jacobs HIL, Schreuder FHBM, van Oostenbrugge RJ, Backes WH, Verhey FR, et al. Blood‐brain barrier dysfunction in small vessel disease related intracerebral hemorrhage. Front Neurol. 2018;9:926.
Yamazaki Y, Kanekiyo T. Blood‐brain barrier dysfunction and the pathogenesis of Alzheimer's disease. Int J Mol Sci. 2017;18(9):1965.
Liu CC, Yamazaki Y, Heckman MG, Martens YA, Jia L, Yamazaki A, et al. Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease. Alzheimers Dement. 2020;16(10):1372–1383.
Kozberg MG, Yi I, Freeze WM, Auger CA, Scherlek AA, Greenberg SM, et al. Blood‐brain barrier leakage and perivascular inflammation in cerebral amyloid angiopathy. Brain Commun. 2022;4(5):fcac245.
Carrano A, Hoozemans JJ, van der Vies SM, van Horssen J, de Vries HE, Rozemuller AJ. Neuroinflammation and blood‐brain barrier changes in capillary amyloid angiopathy. Neurodegener Dis. 2012;10(1–4):329–331.
Hartz AMS, Bauer B, Soldner ELB, Wolf A, Boy S, Backhaus R, et al. Amyloid‐β contributes to blood‐brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke. 2012;43(2):514–523.
Rosas‐Hernandez H, Cuevas E, Raymick JB, Robinson BL, Sarkar S. Impaired amyloid Beta clearance and brain microvascular dysfunction are present in the Tg‐SwDI mouse model of Alzheimer's disease. Neuroscience. 2020;440:48–55.
Magaki S, Tang Z, Tung S, Williams CK, Lo D, Yong WH, et al. The effects of cerebral amyloid angiopathy on integrity of the blood‐brain barrier. Neurobiol Aging. 2018;70:70–77.
Hashimoto Y, Greene C, Munnich A, Campbell M. The CLDN5 gene at the blood‐brain barrier in health and disease. Fluids Barriers CNS. 2023;20(1):22.